Journal article
Recommendations for laboratory workflow that better support centralised amalgamation of genomic variant data: findings from CanVIG-UK national molecular laboratory survey
- Abstract:
- BACKGROUND: National and international amalgamation of genomic data offers opportunity for research and audit, including analyses enabling improved classification of variants of uncertain significance. Review of individual-level data from National Health Service (NHS) testing of cancer susceptibility genes (2002-2023) submitted to the National Disease Registration Service revealed heterogeneity across participating laboratories regarding (1) the structure, quality and completeness of submitted data, and (2) the ease with which that data could be assembled locally for submission. METHODS: In May 2023, we undertook a closed online survey of 51 clinical scientists who provided consensus responses representing all 17 of 17 NHS molecular genetic laboratories in England and Wales which undertake NHS diagnostic analyses of cancer susceptibility genes. The survey included 18 questions relating to 'next-generation sequencing workflow' (11), 'variant classification' (3) and 'phenotypical context' (4). RESULTS: Widely differing processes were reported for transfer of variant data into their local LIMS (Laboratory Information Management System), for the formatting in which the variants are stored in the LIMS and which classes of variants are retained in the local LIMS. Differing local provisions and workflow for variant classifications were also reported, including the resources provided and the mechanisms by which classifications are stored. CONCLUSION: The survey responses illustrate heterogeneous laboratory workflow for preparation of genomic variant data from local LIMS for centralised submission. Workflow is often labour-intensive and inefficient, involving multiple manual steps which introduce opportunities for error. These survey findings and adoption of the concomitant recommendations may support improvement in laboratory dataflows, better facilitating submission of data for central amalgamation.Published version, accepted version, submitted versionRD&E staff can access the full-text of this article by clicking on the 'Additional Link' above and logging in with NHS OpenAthens if prompted
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 658.8KB, Terms of use)
-
- Publisher copy:
- 10.1136/jmg-2023-109645
Authors
+ Cancer Research UK
More from this funder
- Funder identifier:
- 10.13039/501100000289
- Grant:
- C61296/A27223
+ NIHR Cambridge Biomedical Research Centre
More from this funder
- Funder identifier:
- 10.13039/501100018956
- Grant:
- NIHR203312
- Publisher:
- BMJ Publishing Group
- Journal:
- Journal of Medical Genetics More from this journal
- Volume:
- 61
- Issue:
- 4
- Pages:
- 305-312
- Publication date:
- 2023-12-22
- Acceptance date:
- 2023-10-28
- DOI:
- EISSN:
-
1468-6244
- ISSN:
-
0022-2593
- Language:
-
English
- Keywords:
- Pubs id:
-
1591780
- Local pid:
-
pubs:1591780
- Source identifiers:
-
W4390311732
- Deposit date:
-
2026-06-04
- ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.
Terms of use
- Copyright date:
- 2023
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record